GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Webmd Health Corp (WBMD) [hlAlert]

Rating:
Buy WBMD
down 23.22 %

Webmd Health Corp (WBMD) rated Buy with price target $44 by Canaccord Genuity

Posted on: Tuesday,  Jul 19, 2011  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Webmd Health Corp (NASDAQ: WBMD) on 07/19/2011. Previously Canaccord Genuity rated Buy Webmd Health Corp (NASDAQ: WBMD) on
04/19/2011., when the stock price was $53.86. Since then, Webmd Health Corp has lost 23.23% as of 01/07/2016's recent price of $41.35.
If you would have followed the previous Canaccord Genuity's recommendation on WBMD, you would have lost 23.22% of your investment in 1724 days.

WebMD announced today that is has signed an agreement to acquire Conceptis Technologies Inc., a Montreal-based provider of online and offline medical education and promotion aimed at physicians and other healthcare professionals. Conceptis has been successful in developing a strong online presence in the cardiology community and is highly respected for the depth and breadth of content contained on its flagship. With the combination of two of the leading cardiology channels on the Internet, Medscape Cardiology and www.theheart.org, WebMD is well positioned to further its lead and penetration in this high value segment of medical marketing.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/19/2011 9:25 AM Buy
None
33.09 44.00
as of 12/30/2011
1 Week down  -2.06 %
1 Month up  3.67 %
3 Months up  24.54 %
1 YTD up  13.47 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/19/2011 11:25 AM Buy
None
53.86 65.00
8/4/2010 11:25 AM Hold
None
47.68 48.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy